The Global Drug Survey is an online survey that aimed to explore the experience of people who use drugs in general population. This survey is conducted annually between November and December. This special Covid-19 component was conducted over seven weeks, from May to June 2020. The objective of the survey was to retrospectively explore the impact of confinement and the first weeks after lockdown on the consumption of psychoactive products in the general population. The results of the survey show an increase in the number of drinking days, but no increase in binge drinking. For cannabis, use remained relatively stable, although a relative increase compared to other countries was observed. The trends of ecstasy and cocaine uses in particular declined. Finally, benzodiazepines have seen their use increase. The Global Drug Survey notes that the pandemic has changed the patterns of use of psychoactive products, without an increase in deregulated behaviours being observed. People who use drugs have adapted their practices in line with changes in their social environment.
|Translated title of the contribution||Consumption of alcohol and other psychoactive drugs during the COVID-19 pandemic in the global drug survey: A French perspective|
|Journal||Psychotropes - Revue internationale des toxicomanies et des addictions|
|Publication status||Published - 2020|
- drug policy
- Drug markets